Funding of £5m will create new jobs in Norfolk

Published: 28-Jan-2010
Manufacturing Research & Development Finance Pharmaceutical

Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK

Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK with £5m of funding from a partnership including the Biotechnology and Biological Sciences Research Council (BBSRC).

The new development will be based at Norwich Science Park and provide facilities for start-up and expanding businesses.

BBSRC will provide £500,000 as well as the land and buildings to host the new facilities, with £1.4m coming from the East of England Development Agency (EEDA), £1m from the Greater Norwich Development Partnership (GNDP), £500,000 from NRP partner the University of East Anglia (UEA), and the remainder from other NRP partners.

The new facilities, to be opened in July, will be managed by a new joint venture company called Colney Innovations (CIL).

David Parfrey, BBSRC director of finance and director of CIL, said: "The research carried out by the 2,000 scientists already working at Norwich Science Park is world-class and it makes absolute sense to create a facility on this site where the results of such research can be taken through to applications."

Prof Douglas Kell, chief executive of BBSRC, added: "The Norwich Research Park is home to three world-class BBSRC institutes: the John Innes Centre, the Institute of Food Research and The Genome Analysis Centre. This new facility will play a key role in helping our scientists, and others, to translate their excellent science into products to benefit the economy and people of the UK."




See more

You may also like

Pharmaceutical

Cytiva and Fida Biosystems unite to improve molecular insight for faster drug discovery

Read more
The collaboration will combine complementary and orthogonal approaches to simplify workflows and improve confidence in experimental results

Trending Articles

  1. Manufacturing Chemist Stand Side with Piramal Pharma Solutions We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  2. Thermo Fisher launches general purpose centrifuges with natural refrigerant cooling New X and S Series models offer high performance with reduced environmental impact
  3. Rentschler Biopharma and Coriolis Pharma partner to deliver integrated biopharma development and manufacturing solutions The German-based CDMO and CRDO will offer unified formulation-to-manufacturing services to accelerate biologics development. The collaboration aims to cut complexity, timelines and risk for global biopharma clients
  4. Thermo Fisher Scientific doubles down on investment in Asia New and expanded Bioprocess Design Centres will provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

You may also like

Pharmaceutical

Cytiva and Fida Biosystems unite to improve molecular insight for faster drug discovery

The collaboration will combine complementary and orthogonal approaches to simplify workflows and improve confidence in experimental results
Manufacturing

Irish CDMOs Gaelic Labs and Athlone merge to expand penicillin manufacturing capacity

Gaelics acquisition of the leading developer and manufacturer of oral dose Beta-Lactams will strengthen its market position and enhance the company's manufacturing capabilities
Manufacturing

BIA report highlights UK innovation and efficiency in global cell and gene therapy sector

The report provides a comprehensive analysis of the UK's cell and gene therapy sector, focusing on the innovative technologies and strategic investments that are driving scale
Manufacturing

Vacuubrand at a glance - New brochure available to download

In the UK, Labtex supplies a comprehensive range of high-quality laboratory and instrumentation vacuum pumps, gauges and controllers for both coarse and fine vacuums, from trusted partners at Vacuubrand
Manufacturing

SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production

The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the retina, such as dry age-related macular degeneration
Pharmaceutical

SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain

Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
Research & Development

Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme

Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research programme titled RISE (Reducing Immune Stress from Excess cytokine release in advanced therapies)
Subscribe now